
Health
FG approves Oxford Malaria vaccine for use in Nigeria
NAFDAC DG
The federal government has granted provisional approval for the Malaria Vaccine, R21/Matrix developed by scientists at Oxford University for use in Nigeria.
Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Professor Mojisola Adeyeye, at a press briefing on Monday said the vaccine would be used for the prevention of malaria in children from 5 months to 36 months of age.
With the provisional approval of the vaccine manufactured by the Serum Institute of India, Nigeria became the second country to approve the new malaria vaccine from Oxford University after Ghana.
She declared that the agency received the dossier of the vaccine and subjected it to independent review by experts from Nigeria’s tertiary institutions and the agency’s in-house vaccine review committee and said it met the criteria for efficacy, safety, and quality.

According to her, while the review committee recognised that the vaccine is 75 per cent effective in protecting against malaria, the vaccine’s potential benefits outweigh its known and potential risks, thereby supporting the manufacturer’s recommended use.
The DG noted that Nigeria has the highest burden for malaria in the continent hence, having an efficacious vaccine was crucial to protect millions of children.
Prof Adeyeye said that Nigeria is expected to get at least 100,000 doses of the vaccine in donations soon before the market authorisation starts making other arrangements with the National Primary Health Care Development Agency (NPHCDA).
According to her, “NAFDAC in exercising its mandate as stipulated by its enabling law, NAFDAC Act CapN1, LFN 2004 is granting registration approval for R21 Malaria Vaccine (Recombinant, Adjuvanted) manufactured by Serum Institute of India Pvt. Ltd. (SIIPL).
“The Marketing Authorization Holder is Fidson Healthcare Ltd in line with the Agency’s Drug and Related Products Registration Regulation 2021.
“A provisional approval of the R21 Malaria Vaccine was recommended and this shall be done in line with the World Health Organization’s (WHO’s) Malaria Vaccine Implementation Guideline.”
Professor Adeyeye, however, said with the provisional approval of the R21 Malaria Vaccine for use in Nigeria, the Agency has also communicated the need for expansion of the clinical trial in its phase 4 clinical trial/Pharmacovigilance study phase to be carried out also in Nigeria.
In a remark, Dr Babatunde Ogunbosi, a consultant paediatrician at the University College Hospital (UCH), Ibadan, said a malaria vaccine is a good tool and a welcome development that should be added to other interventions to control malaria in the country.
Director and Professor of Pediatrics and Child Health at the Institute of Child Health, University of Ibadan, Professor Adebola Orimadegun said the Oxford Malaria Vaccine is a welcome development given that more modern and potent approaches are needed for malaria eradication in Nigeria.
“We need to engage in a more modern and potent approach to malaria eradication in Nigeria; it is highly required because Nigeria is contributing so much to the malaria global burden. So it is a good thing that Nigeria has adopted it.
“Just like a vaccination against other vaccine-preventable diseases has effectively cut down deaths, I have no doubt that this also will work for our children. However, other aspects of malaria control need to be scaled up or further emphasized. For instance, we need attitudinal change if we must eradicate malaria.”
Prof Orimadegun added that there is no better time than now to approve the malaria vaccine of use in Nigeria because there is evidence for the emergence of resistance to the most potent malaria medicine, Artemisinin-based combination treatments (ACTs), currently used in Nigeria.
“Researcher is reporting a few cases of Artemisinin-resistant malaria in Nigeria, though we don’t have sufficient evidence yet.
“In our recent trial, we found that the efficacy of Artemisinin-based combination treatments (ACTs) is relatively lower compared with a new antimalarial medicine called Pyronaridine. That is not good news for us because Pyronaridine is very expensive and not yet widely available. That is why I am happy for the vaccination to begin. There is no better time than now.”
Health
Mbah tours 300-Bed Enugu Int’l Hospital, says ‘We’re ready to welcome the world’ (PHOTOS)
…Set to launch hospital, targets large share of medical tourism
_…Facility attracts outpouring of interest from diaspora medics
Ahead of the imminent inauguration of the Enugu International Hospital, Governor Peter Mbah of Enugu State has undertaken a tour of the facility, declaring that Enugu State was ready to welcome the world.
Mbah said the hospital was now fully installed with state-of-the-art medical equipment and would help to reverse medical tourism out of the country, ensuring that the state secures a large chunk of the multibillion-dollar market.
Fielding questions from newsmen on Thursday evening after a pre-launch walkthrough of the facility situated at Rangers Avenue, Independence Layout, Enugu, Mbah said the hospital was a product of a deliberate health agenda.

“If you recall our manifesto during our campaign for office, we made it clear that we were committed to making Enugu a medical tourism hub on the continent.

“We knew the size of that market and wanted to have a good share of that market. But we knew also that it was never going to be wished into existence.
“We knew that we needed to do things differently and build a world-class facility and, most importantly, attract top-notch professionals to provide services. We cannot wait to welcome the world to Enugu,” he stated.

Mbah regretted that there was just about one functional location for PET Scan services in the country, but noted that the hospital would now bridge the wide gap in advanced medical services in the country.
“We have quite a lot of Ndi Enugu, and Nigerians who travel to India, Turkey, the United States, and the United Kingdom to seek medical attention. So, what we are asking for is just a fraction of what they would have spent overseas for the same quality services,” he said.
“We felt that if we want to compete globally, then we must also have the ability to provide advanced oncology services. Therefore, we are not only able to give you an advanced diagnosis, but we’re also able to treat. So, both diagnostically and therapeutically, the place to come to is right here in Enugu.
“We have also received an outpouring of interest from our healthcare professionals in the diaspora. Some of them were doing well here at some point and now went overseas to practice. They are now happy to come back home and give back to the society that nurtured them. We are excited about that,” he stated.
He added that the Enugu International Hospital would equally engage in telemedicine as one of its areas of strength.
“Of course, you may be in love with the building and the equipment, but you should also engage professionals from across the globe. You see this in our commitment to telemedicine, digital and electronic medical practices and equipment,” he explained.
He emphasised that the hospital was part of his administration’s agenda for the health sector as a major part of his government’s vision to grow the state’s economy from $4.4bn to $30bn, and ensure high quality and increased life expectancy for the people.
“If you look at our intervention in the healthcare sector, from the primary healthcare to the secondary, tertiary, and now the quaternary, it is intentional.
“We are investing heavily in security and healthcare because we know that these are what investors would ask you: ‘Am I safe? If I fall sick, would I have a place where I can get quality medical attention?’” he said, adding that the hospital would also create jobs.
Speaking, the Chief Executive Officer, Prof. Sam Agwu, listed six specialty areas the hospital would provide services in once commissioned.
“We have earmarked six specialty centres here. In the Cancer Centre, we are going to provide medical, surgical, and nuclear medicine therapeutics and diagnostics.
“Then we are going to have the Heart and Vascular Centre of Excellence to deal with all heart problems and open-heart surgery, as you may know; cardiology consultation and diagnostics, electrophysiology and arrhythmia care, coronary care and acute cardiac pathways, interventional cardiology and cath-lab procedures, heart-failure and cardiac rehabilitation clinics, and of course vascular assessment and collaborative surgical care.
“We are going to have the Neurosciences Centre where we will deal with stroke, epilepsy, brain and spine tumours, neurosurgical procedures, among others.
“We are going to have a Renal and Transplant Centre of Excellence covering full kidney, chronic kidney disease clinics, early nephrology review, dialysis support and transplant assessment.
“Then, apart from all the centres of excellence, we are going to have wellness and regenerative medicine, while the usual departments that you know of – mother and child, general surgery, ENT, dental, ophthalmology, among others – will all be here.
Former Chairman of the Nigerian Medical Association, Enugu State, Dr. Sunday Nwafor, hailed the milestone, saying the hospital would promote brain gain by reversing the mass exodus of medical doctors from the country.
“Going forward, our doctors have a place of international standard where they can practice with state-of-the-art equipment and also earn well,” he said.
Mbah was accompanied by the Commissioner for Health, Prof. George Ugwu, among others.
MORE PHOTOS

Health
NAFDAC urges Stakeholders to lead vigilance on Antimicrobial Resistance, Adverse Drug Reactions
The National Agency for Food and Drug Administration and Control (NAFDAC) has called on stakeholders and Nigerians to lead vigilance against Antimicrobial Resistance (AMR) to medicines/drugs and Adverse Drug Reactions (ADR).
The Director-General of NAFDAC, Prof. Mojisola Adeyeye, made the call on during a one-day Pharmacovigilance Workshop and Stakeholders Town Hall Meeting in Enugu.
Represented by NAFDAC’s Director, South-East Zone, Dr Festus Ukadike, the director-general noted that the gravest consequences of irrational medicine use today is AMR.
She explained that the misuse and overuse of antibiotics had accelerated the emergence of resistant microorganisms that no longer respond to conventional treatment.
“This means that infections previously treatable with common antibiotics are becoming increasingly difficult and expensive to manage.

“If urgent action is not taken, antimicrobial resistance may reverse decades of medical progress and place humanity at serious risk.
“This is why Pharmacovigilance is extremely important. Pharmacovigilance refers to the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems.
“In simple terms, Pharmacovigilance helps us ensure that medicines remain safe and effective even after they have been approved and released into the market,” she said.
Adeyeye noted that no medicine is completely free from side effects.
“However, through effective Pharmacovigilance systems, healthcare professionals and patients can identify harmful reactions early, report them appropriately, and help regulatory authorities take necessary actions to protect the public,” she said.
She said that Pharmacovigilance remained a core mandate of the agency, adding that stakeholders and general public should play active part in monitoring AMR and ADR to ensure effectiveness of medicine and treatment.
Speaking, the Chairman, Enugu State Traditional Rulers’ Council, Igwe Samuel Asadu, commended NAFDAC for the workshop, while urging the agency to put more effort in curbing sales of fake medicines in the hinterlands.
Asadu said that Pharmacovigilance was needed more in the hinterlands of the state to stop people paddling fake medicines and “selling outright chalk as medicine in villages in the state”.
He gave the commitment of royal fathers in the state in providing necessary support to NAFDAC to check paddlers of fake medicines, “as we see our people die due to their activities.”
Corroborating, the State Coordinator of World Health Organization (WHO), Dr Adaeze Ugwu, said that the organisation would continue to support NAFDAC in the agency’s resolve to strengthen food and healthcare in the country.
Also, Dr Oliver Ezemba, Chairman, Nigerian Association of Patent and Proprietory Medicine Dealers (NAPPMED), urged everybody to get concerned on the issues of AMR and ADR to guarantee quality medicines for everyone.
Ezemba called on Nigerians to imbibe the habit of reporting any irregularities observed while using a medicine to NAFDAC for proper investigation, which would serve the benefit of many Nigerians using same medicine.
The participants asked questions on AMR and ADR as well as made pledge on reporting any suspectable AMR or ADR case through the NAFDAC’s Med Safety Mobile App using their cellphone or computer set.
In the workshop, a presentation was made on “Need for Effective Pharmacovigilance by All’, delivered by Mr Chidi Uche and Mrs Ogechi Udeh, who are NAFDAC officials.
Health
How Gov Peter Mbah is rewriting Enugu’s healthcare story
By Dr. Collins Ogbu
In the life of every society, there comes a defining moment when leadership either sustains the status quo or boldly reimagines the future. For Enugu State, that moment is now. At the centre of this transformation is Governor Peter Ndubuisi Mbah, whose administration is not merely responding to challenges in the health sector but fundamentally rebuilding it. Recent public discourse surrounding the suspension of a health assistant trainee by a private institution has, perhaps inadvertently, created an opportunity to restate a deeper truth: the Enugu State Government remains focused, deliberate, and fully committed to repositioning healthcare delivery across the state.
For years, Enugu’s healthcare system reflected a troubling pattern familiar in many subnational contexts; underfunded primary healthcare centres, overstretched personnel, aging and inadequate infrastructure, and an overreliance on private or out-of-state medical services. Rural communities were particularly disadvantaged, often forced to travel long distances for basic care. Training institutions operated with limited capacity, while secondary and tertiary facilities struggled with outdated equipment and insufficient staffing. The system was largely reactive, constrained by years of neglect and unable to meet the growing needs of the population.
Governor Mbah’s administration has decisively broken from that past. Anchored on the principle that healthcare is a right and not a privilege, the government undertook a comprehensive audit of the sector and initiated a far-reaching reform agenda. Rather than incremental adjustments, the approach has been bold and systemic; targeting every layer of healthcare delivery, from primary care to specialised services.
Central to this transformation is the rollout of 260 Type-2 Primary Healthcare Centres across all political wards in the state. This initiative directly addresses the longstanding gap in grassroots healthcare access. Where communities once depended on poorly equipped facilities or distant hospitals, modern, well-positioned centres are now being established to provide quality care within reach. This effort is further strengthened by the recruitment of over 2,250 healthcare workers, a significant intervention aimed at resolving the manpower shortages that previously undermined service delivery.

At the secondary level, general hospitals are undergoing extensive rehabilitation to restore their capacity as reliable referral centres. Facilities such as Uwani General Hospital, which once symbolised infrastructural decline, are being transformed to meet modern standards. These upgrades are ensuring a more efficient continuum of care between primary and tertiary institutions.
The transformation is even more pronounced in tertiary healthcare. The Enugu State University Teaching Hospital (ESUTH), Parklane, is experiencing unprecedented infrastructural expansion, including the construction of a twin six-floor Laboratory and Clinical Complex, a seven-floor Nursing Complex equipped with advanced diagnostic facilities, and a modern Accident and Emergency Department. These developments represent a significant leap from the limitations of the past, positioning the institution as a centre of excellence in both service delivery and medical training.
In the area of medical education, the administration has recorded a landmark achievement with the reaccreditation of the ESUT College of Medicine and the subsequent increase in its admission quota to 350 students – the highest among state-owned institutions in Nigeria. This milestone reflects a strategic commitment to building human capital and ensuring a steady pipeline of highly trained medical professionals for the future.
Equally significant is the completion of the State University of Medical and Applied Sciences (SUMAS) Teaching Hospital in Igbo-Eno. Unlike in previous years when a single teaching hospital struggled to meet demand, Enugu now has a second fully equipped facility, with recruitment already underway to commence full-scale operations. This expansion not only improves access to tertiary care but also strengthens the state’s capacity for medical training and research.
Crowning these efforts is the nearly completed 300-bed Enugu International Hospital, a state-of-the-art, super-specialist facility designed to elevate healthcare standards and reduce the need for outbound medical tourism. For decades, many residents sought advanced medical care outside the state or country, often at great financial and emotional cost. This facility represents a turning point, offering world-class services within Enugu and reinforcing the state’s emergence as a healthcare hub.
Amid these sweeping reforms, the government has also demonstrated a strong commitment to transparency and responsible governance. By clearly distancing itself from the internal disciplinary processes of a private institution while engaging relevant stakeholders, it underscores respect for institutional autonomy alongside responsiveness to public concerns.
What is unfolding in Enugu today is not merely policy execution but a comprehensive transformation. The contrast between the past and the present is both clear and compelling; where there were once gaps, there is now structure; where there was decline, there is now renewal. The state is moving from a system defined by limitations to one driven by vision, investment, and measurable progress.
While challenges inevitably remain, the trajectory is unmistakable.
Enugu State is no longer managing a fragile healthcare system; it is building a resilient, modern, and inclusive one. In the final analysis, Governor Peter Ndubuisi Mbah’s strides in the health sector are redefining not just infrastructure and policy, but the very experience of healthcare for Ndi Enugu, laying the foundation for a future where quality care is accessible, reliable, and sustainable for all.
• By Dr. Ogbu is a Senior Special Assistant, SSA to Enugu State Governor on Strategic Communications
-
News3 days ago‘Fake agency’ boss, Nwabueze, fights back with appointment letter
-
News2 days agoNDLEA arrests 101-year-old woman for selling cannabis in Ogun
-
News3 days ago‘How fake federal agency tricked us’ – Anambra govt
-
News2 days agoTerrorists abduct many worshippers from Niger Central Mosque
-
Entertainment7 hours agoDolly Parton, Queen of Country Music, dies at 80
-
News2 days agoInsecurity: Nigeria must not become a killing field — Obi tells FGi
-
News3 days agoAtiku breaks silence on FBI’s refusal to make Tinubu records public
-
News1 day agoAtiku’s Subsidy Reversal: Desperation For Power Must Not Endanger Nigeria’s Economy-Yilwatda




